168 related articles for article (PubMed ID: 9542584)
41. Proteins of interstitial cells of Cajal and intestinal smooth muscle, colocalized with caveolin-1.
Cho WJ; Daniel EE
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G571-85. PubMed ID: 15472013
[TBL] [Abstract][Full Text] [Related]
42. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex.
Crosbie RH; Yamada H; Venzke DP; Lisanti MP; Campbell KP
FEBS Lett; 1998 May; 427(2):279-82. PubMed ID: 9607328
[TBL] [Abstract][Full Text] [Related]
43. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.
Chang WJ; Iannaccone ST; Lau KS; Masters BS; McCabe TJ; McMillan K; Padre RC; Spencer MJ; Tidball JG; Stull JT
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9142-7. PubMed ID: 8799168
[TBL] [Abstract][Full Text] [Related]
44. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
[TBL] [Abstract][Full Text] [Related]
45. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
46. Localization of sarcoglycan, neuronal nitric oxide synthase, beta-dystroglycan, and dystrophin molecules in normal skeletal myofiber: triple immunogold labeling electron microscopy.
Wakayama Y; Inoue M; Kojima H; Murahashi M; Shibuya S; Oniki H
Microsc Res Tech; 2001 Nov; 55(3):154-63. PubMed ID: 11747090
[TBL] [Abstract][Full Text] [Related]
47. NO message from muscle.
Grozdanovic Z
Microsc Res Tech; 2001 Nov; 55(3):148-53. PubMed ID: 11747089
[TBL] [Abstract][Full Text] [Related]
48. Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx-dystrophic mice: an immunocytochemical study.
Nahirney PC; Ovalle WK
Anat Rec; 1993 Apr; 235(4):501-10. PubMed ID: 8465985
[TBL] [Abstract][Full Text] [Related]
49. Nitric oxide synthase II in rat skeletal muscles.
Punkt K; Naupert A; Wellner M; Asmussen G; Schmidt C; Buchwalow IB
Histochem Cell Biol; 2002 Nov; 118(5):371-9. PubMed ID: 12432448
[TBL] [Abstract][Full Text] [Related]
50. Accumulation of caveolin-3 protein is limited in damaged muscle in chicken muscular dystrophy.
Matsumoto H; Sasazaki S; Fujiwara A; Ichihara N; Kikuchi T; Mannen H
Comp Biochem Physiol A Mol Integr Physiol; 2010 Sep; 157(1):68-72. PubMed ID: 20451648
[TBL] [Abstract][Full Text] [Related]
51. Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro.
Liu L; Vachon PH; Kuang W; Xu H; Wewer UM; Kylsten P; Engvall E
Biochem Biophys Res Commun; 1997 Jun; 235(1):227-35. PubMed ID: 9196068
[TBL] [Abstract][Full Text] [Related]
52. Irregular costameres represent nitric oxide synthase-1-positive sarcolemma invaginations enriched in contracted skeletal muscle fibres.
Baum O; Planitzer G; Richter H; Gossrau R
Histochem J; 2000 Dec; 32(12):743-51. PubMed ID: 11254090
[TBL] [Abstract][Full Text] [Related]
53. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins.
Song KS; Scherer PE; Tang Z; Okamoto T; Li S; Chafel M; Chu C; Kohtz DS; Lisanti MP
J Biol Chem; 1996 Jun; 271(25):15160-5. PubMed ID: 8663016
[TBL] [Abstract][Full Text] [Related]
54. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.
Lapidos KA; Kakkar R; McNally EM
Circ Res; 2004 Apr; 94(8):1023-31. PubMed ID: 15117830
[TBL] [Abstract][Full Text] [Related]
55. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
56. Expression of neuronal nitric oxide synthase in fast rat skeletal muscle.
Vranić TS; Bobinac D; Jurisić-Erzen D; Muhvić D; Sandri M; Jerković R
Coll Antropol; 2002 Dec; 26 Suppl():183-8. PubMed ID: 12674853
[TBL] [Abstract][Full Text] [Related]
57. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.
Chao DS; Silvagno F; Bredt DS
J Neurochem; 1998 Aug; 71(2):784-9. PubMed ID: 9681470
[TBL] [Abstract][Full Text] [Related]
58. Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity.
Sunada Y; Ohi H; Hase A; Ohi H; Hosono T; Arata S; Higuchi S; Matsumura K; Shimizu T
Hum Mol Genet; 2001 Feb; 10(3):173-8. PubMed ID: 11159934
[TBL] [Abstract][Full Text] [Related]
59. Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase.
Wehling M; Stull JT; McCabe TJ; Tidball JG
Neuromuscul Disord; 1998 Feb; 8(1):22-9. PubMed ID: 9565987
[TBL] [Abstract][Full Text] [Related]
60. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
Volonte D; Peoples AJ; Galbiati F
Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
